· Updated March 2026 Best Stocks to Invest in 2025 & Beyond
8 min read

Best Stocks to Invest in 2025 & Beyond

Long-term picks for a resilient, diversified, and profitable portfolio.

Building a robust and resilient portfolio demands a strategic approach to equity selection, a process that becomes increasingly critical as we evaluate the best stocks to invest in 2025. The transition from previous market cycles into the mid-2020s has been characterized by evolving inflation dynamics, shifting interest rate expectations, and profound technological integration across all sectors. Investors asking what are the best stocks to invest in must now consider not only historical performance but also how companies are adapting to a rapidly changing global economy.

In assessing the best stocks to invest in 2024, the market rewarded companies with immense scale and cash reserves, particularly within the technology sector. However, as we look forward, the criteria for the best stocks to invest in 2026 emphasize durability, pricing power, and consistent shareholder returns through dividends and share buybacks. The equities featured in this guide represent a cross-section of industries, from consumer defensive stalwarts to innovative healthcare providers, each selected for their potential to anchor a long-term investment strategy.

This comprehensive analysis provides real-time data, including current prices, P/E ratios, and dividend yields, allowing you to filter and sort based on your investment priorities. Whether you are constructing a portfolio from scratch or rebalancing existing holdings, understanding the fundamental drivers behind these companies is paramount. The best stocks to invest in are ultimately those that align with your financial objectives, risk tolerance, and time horizon, providing both capital appreciation and income generation over the years to come.

Filter the Data

Ticker ↕Name ↕Sector ↕Price ↕Yield ↕P/E Ratio ↕Market Cap ↕
BRK-BBerkshire Hathaway Inc. NewFinancial Services$490.03N/A15.80$1.06T
VVisa Inc.Financial Services$307.140.87%28.81$592.18B
JNJJohnson & JohnsonHealthcare$241.522.15%21.88$582.04B
WMTWalmart Inc.Consumer Defensive$126.520.78%46.34$1.01T
PGProcter & Gamble Company (The)Consumer Defensive$150.652.81%22.32$352.59B
UNHUnitedHealth Group IncorporatedHealthcare$282.093.13%21.32$256.05B
MAMastercard IncorporatedFinancial Services$497.990.70%30.13$444.43B
HDHome Depot, Inc. (The)Consumer Cyclical$339.032.75%23.81$337.51B
COSTCostco Wholesale CorporationConsumer Defensive$1008.430.52%52.36$447.43B
ABBVAbbVie Inc.Healthcare$219.683.15%92.69$388.43B

Detailed Equity Analysis

Below is a comprehensive breakdown of each stock in our list. By combining fundamental metrics like valuation multiples and dividend yields with qualitative analysis of company operations and sector dynamics, investors can make more informed portfolio allocation decisions.

BRK-B - Berkshire Hathaway Inc. New

Sector: Financial Services | Price: $490.03 | Yield: N/A | P/E: 15.80 | Market Cap: $1.06T

Berkshire Hathaway Inc., together with its subsidiaries, engages in the insurance, freight rail transportation, and utility businesses. The company provides property, casualty, life, accident, and hea...

Compare BRK-B metrics →

V - Visa Inc.

Sector: Financial Services | Price: $307.14 | Yield: 0.87% | P/E: 28.81 | Market Cap: $592.18B

Visa Inc. operates as a payment technology company in the United States and internationally.

Compare V metrics →

JNJ - Johnson & Johnson

Sector: Healthcare | Price: $241.52 | Yield: 2.15% | P/E: 21.88 | Market Cap: $582.04B

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech.

Compare JNJ metrics →

WMT - Walmart Inc.

Sector: Consumer Defensive | Price: $126.52 | Yield: 0.78% | P/E: 46.34 | Market Cap: $1.01T

Walmart Inc. engages in the operation of retail and wholesale stores and clubs, eCommerce websites, and mobile applications worldwide.

Compare WMT metrics →

PG - Procter & Gamble Company (The)

Sector: Consumer Defensive | Price: $150.65 | Yield: 2.81% | P/E: 22.32 | Market Cap: $352.59B

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care segments.

Compare PG metrics →

UNH - UnitedHealth Group Incorporated

Sector: Healthcare | Price: $282.09 | Yield: 3.13% | P/E: 21.32 | Market Cap: $256.05B

UnitedHealth Group Incorporated operates as a health care company in the United States and internationally. It operates through four segments: Optum Health, Optum Insight, Optum Rx; and UnitedHealthcare.

Compare UNH metrics →

MA - Mastercard Incorporated

Sector: Financial Services | Price: $497.99 | Yield: 0.70% | P/E: 30.13 | Market Cap: $444.43B

Mastercard Incorporated, a technology company, provides transaction processing and other payment-related products and services in the United States and internationally.

Compare MA metrics →

HD - Home Depot, Inc. (The)

Sector: Consumer Cyclical | Price: $339.03 | Yield: 2.75% | P/E: 23.81 | Market Cap: $337.51B

The Home Depot, Inc. operates as a home improvement retailer in the United States and internationally.

Compare HD metrics →

COST - Costco Wholesale Corporation

Sector: Consumer Defensive | Price: $1008.43 | Yield: 0.52% | P/E: 52.36 | Market Cap: $447.43B

Costco Wholesale Corporation, together with its subsidiaries, engages in the operation of membership warehouses in the United States, Puerto Rico, Canada, Mexico, Japan, the United Kingdom, Korea, Australia, Taiwan, China, Spain, France, Iceland, New Zealand, and Sweden.

Compare COST metrics →

ABBV - AbbVie Inc.

Sector: Healthcare | Price: $219.68 | Yield: 3.15% | P/E: 92.69 | Market Cap: $388.43B

AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide.

Compare ABBV metrics →

Our Methodology and Market Approach

Understanding how we select and analyze equities is crucial for making informed investment decisions. Our proprietary methodology involves a rigorous, multi-factor screening process designed to identify companies with durable competitive advantages, robust financial health, and compelling valuation metrics. We begin by defining the investable universe, which typically includes large-cap and mid-cap equities trading on major global exchanges.

The first pillar of our analysis focuses on fundamental financial metrics. We meticulously review income statements, balance sheets, and cash flow statements to assess a company's profitability, leverage, and liquidity. Key indicators such as the Price-to-Earnings (P/E) ratio, Price-to-Book (P/B) ratio, and Free Cash Flow (FCF) yield are evaluated relative to industry peers and historical averages. A company must demonstrate consistent revenue growth and expanding profit margins to warrant consideration. Furthermore, we pay close attention to return on invested capital (ROIC), as it is a strong indicator of management's ability to efficiently allocate capital.

Beyond quantitative metrics, our methodology heavily weights qualitative factors. We conduct deep-dive research into the competitive landscape of each industry, identifying structural tailwinds and potential disruptive threats. Evaluating a company's economic moat—whether derived from network effects, switching costs, cost advantages, or intangible assets like patents and brand strength—is central to our approach. We look for businesses that can maintain pricing power and protect their market share over the long term.

Frequently Asked Questions

What are the best stocks to invest in 2025?

Identifying the best stocks to invest in 2025 requires balancing growth potential with downside protection. Generally, these include established dividend payers, defensive consumer staples, and healthcare companies that offer stability regardless of economic conditions. Examples often cited for 2025 include Johnson & Johnson, Walmart, and Procter & Gamble, which boast strong balance sheets and pricing power.

What were the best stocks to invest in 2024?

In 2024, the market narrative was predominantly driven by mega-cap technology companies, often referred to as the 'Magnificent Seven.' These firms capitalized on the artificial intelligence boom and robust consumer spending. However, as the year progressed, there was a noticeable rotation into value sectors and small-cap stocks as investors sought broader market participation.

What are the best stocks to invest in?

The overarching question of what are the best stocks to invest in has no single correct answer, as it fundamentally depends on your specific time horizon, risk appetite, and investment objectives. A universally common and effective strategy involves building a diversified core portfolio composed of broad market index funds, supplemented by carefully selected blue-chip dividend stocks for income and stability.

What are the best stocks to invest in 2026?

Looking toward 2026, the focus shifts to sustainability and resilience. The best stocks to invest in for 2026 are companies that maintain sustainable dividend payout ratios, possess the pricing power to navigate inflationary pressures, and operate resilient business models that provide essential goods or services, ensuring steady cash flow across economic cycles.

How do I choose the best stocks?

Choosing the best stocks involves a multifaceted approach combining quantitative and qualitative analysis. Key considerations include evaluating the company's financial health via its balance sheet, understanding its competitive position or 'moat' within the industry, analyzing valuation metrics such as the Price-to-Earnings (P/E) ratio, and aligning the investment with your personal portfolio strategy.

Cite This Page

Westmount Fundamentals. "Best Stocks to Invest in 2025 & Beyond." westmountfundamentals.com/best-stocks-to-invest-in-2025, 2026.